These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34709121)

  • 21. Intersections between syndemic conditions and stages along the continuum of overdose risk among women who inject drugs in Mexicali, Mexico.
    Gonzalez-Nieto P; Salimian A; Arredondo J; Angulo L; García de Loera A; Slim S; Shoptaw S; Cambou MC; Pitpitan EV; Goodman-Meza D
    Harm Reduct J; 2023 Jun; 20(1):79. PubMed ID: 37355611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.
    Boucher LM; Marshall Z; Martin A; Larose-Hébert K; Flynn JV; Lalonde C; Pineau D; Bigelow J; Rose T; Chase R; Boyd R; Tyndall M; Kendall C
    Harm Reduct J; 2017 May; 14(1):18. PubMed ID: 28494774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Narratives of people who inject drugs on factors contributing to opioid overdose.
    Chang JS; Behar E; Coffin PO
    Int J Drug Policy; 2019 Dec; 74():26-32. PubMed ID: 31442677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives.
    May T; Dawes J; Fancourt D; Burton A
    Int J Drug Policy; 2022 Aug; 106():103752. PubMed ID: 35653821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley.
    Friedman J; Syvertsen JL; Bourgois P; Bui A; Beletsky L; Pollini R
    Int J Drug Policy; 2021 Jan; 87():102981. PubMed ID: 33129133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey.
    Khezri M; Karamouzian M; Sharifi H; Ghalekhani N; Tavakoli F; Mehmandoost S; Mehrabi F; Pedarzadeh M; Nejat M; Noroozi A; Baral S; Shokoohi M
    Int J Drug Policy; 2021 Nov; 97():103355. PubMed ID: 34242959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stigma and Human Rights Abuses against People Who Inject Drugs in Russia--A Qualitative Investigation to Inform Policy and Public Health Strategies.
    Lunze K; Lunze FI; Raj A; Samet JH
    PLoS One; 2015; 10(8):e0136030. PubMed ID: 26305697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring what shapes injection and non-injection among a sample of marginalized people who use drugs.
    Ivsins A; Marsh S
    Int J Drug Policy; 2018 Jul; 57():72-78. PubMed ID: 29702394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
    Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
    Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "I don't want to die": a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies.
    Abadie R
    Harm Reduct J; 2023 Jun; 20(1):75. PubMed ID: 37316884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits.
    Folch C; Lorente N; Majó X; Parés-Badell O; Roca X; Brugal T; Roux P; Carrieri P; Colom J; Casabona J;
    Int J Drug Policy; 2018 Dec; 62():24-29. PubMed ID: 30352331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'Safer environment interventions': a qualitative synthesis of the experiences and perceptions of people who inject drugs.
    McNeil R; Small W
    Soc Sci Med; 2014 Apr; 106():151-8. PubMed ID: 24561777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction.
    Guise A; Dimova M; Ndimbii J; Clark P; Rhodes T
    Harm Reduct J; 2015 Sep; 12():27. PubMed ID: 26337729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "The Slums Have To Be Shown": Documenting Drug Injection in Public Spaces Ahead of the Opening of a Drug Consumption Room in Marseille.
    Dos Santos M; Girard G; Briand Madrid L; Perreaut L; Olenine A; Roux P
    Qual Health Res; 2023 Jul; 33(8-9):727-740. PubMed ID: 37271754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negotiating place and gendered violence in Canada's largest open drug scene.
    McNeil R; Shannon K; Shaver L; Kerr T; Small W
    Int J Drug Policy; 2014 May; 25(3):608-15. PubMed ID: 24332972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing and Testing the
    Calvo F; Carbonell X; Mundet C
    Front Public Health; 2020; 8():493321. PubMed ID: 33330297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Navigating environmental constraints to injection preparation: the use of saliva and other alternatives to sterile water among unstably housed PWID in London.
    Harris M; Scott J; Hope V; Wright T; McGowan C; Ciccarone D
    Harm Reduct J; 2020 Apr; 17(1):24. PubMed ID: 32276626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Until people start dying in droves, no actions will be taken": perception and experience of HIV-preventive measures among people who inject drugs in northwestern Russia.
    Meylakhs P; Aasland A; Grønningsæter A
    Harm Reduct J; 2017 Jun; 14(1):33. PubMed ID: 28583120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis.
    Rahimi J; Gholami J; Amin-Esmaeili M; Fotouhi A; Rafiemanesh H; Shadloo B; Rahimi-Movaghar A
    Addiction; 2020 Apr; 115(4):605-622. PubMed ID: 31631425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.